He and a colleague proved a theory advanced by the Nobel Prize winners James Watson and Francis Crick, who discovered DNA’s ...

Myriad Genetics, Inc. MYGN focuses on the expansion of companion diagnostics, market expansion through new clinical guidelines and providing new offerings in its Oncology business. The company ...

Researchers report that eight healthy babies were born with the help of an experimental technique that uses DNA from three ...

Read about Myriad Genetics Inc (MYGN:XNAS) stock and today's latest news and financial updates.

Double-strand breaks are among the most difficult forms of DNA damage for cells to repair because they disrupt the continuity of DNA and leave no intact template to base new strands on.

Our Top 5 Analyst Questions Myriad Genetics’s Q1 Earnings Call ・ Doug Schenkel (Wolfe Research) pressed CEO Sam Raha on how long it would take to simplify Myriad’s business and clarify key ...

Review the current Myriad Genetics Inc (MYGN:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if MYGN is the best investment for you.

undefined pictures and photo gallery -- Check out just released undefined pics, images, clips, trailers, production photos and more from Rotten Tomatoes' pictures archive!